Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
TCT: Abbott atherectomy study fails vs. balloon angioplasty
The Diamondback 360 is designed to etch away at severely calcified lesions, where hardened plaques can make it difficult to expand a heart stent.
Conor Hale
Oct 29, 2024 12:30pm
TCT: Using TAVR early helps prevent later hospitalizations
Oct 28, 2024 11:22am
Dexcom posts mixed-bag earnings report amid Stelo rollout
Oct 25, 2024 1:30pm
FDA approves Medtronic's Affera 2-in-1 afib ablation system
Oct 25, 2024 12:00pm
Medtronic expands reach of latest TAVR valve with EU approval
Oct 24, 2024 1:00pm
Boston Scientific posts 177% EP growth, pauses Farapulse study
Oct 23, 2024 11:58am